Conary Meyer

Conary Meyer

Auto-generated profile, based on publicly available information

Conary Meyer

Department of Biomedical Engineering, University of California, Davis, Davis, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
CMConary Meyer
Conary Meyer
JLJoseph Losacco
Joseph Losacco
ZSZachary Stickney
Zachary Stickney
LLLingxuan Li
Lingxuan Li
GMGerard Marriott
Gerard Marriott
Biao LuBiao Lu
Biao Lu
Exosomes are cell-derived nanovesicles that hold promise as living vehicles for intracellular delivery of therapeutics to mammalian cells. This potential, however, is undermined by the lack of effective methods to load exosomes with therapeutic proteins and to facilitate their uptake by target cells. Here, we demonstrate how a vesicular stomatitis virus glycoprotein (VSVG) can both load protein cargo onto exosomes and increase their delivery ability via a pseudotyping mechanism. By fusing a set of fluorescent and luminescent reporters with VSVG, we show the successful targeting and incorporation of VSVG fusions into exosomes by gene transfection and fluorescence tracking. We subsequently validate our system by live cell imaging of VSVG and its participation in endosomes/exosomes that are ultimately released from transfected HEK293 cells. We show that VSVG pseudotyping of exosomes does not affect the size or distributions of the exosomes, and both the full-length VSVG and the VSVG without the ectodomain are shown to integrate into the exosomal membrane, suggesting that the ectodomain is not required for protein loading. Finally, exosomes pseudotyped with full-length VSVG are internalized by multiple-recipient cell types to a greater degree compared to exosomes loaded with VSVG without the ectodomain, confirming a role of the ectodomain in cell tropism. In summary, our work introduces a new genetically encoded pseudotyping platform to load and enhance the intracellular delivery of therapeutic proteins via exosome-based vehicles to target cells.

11 June 2021 in Life
Verified
Journal Article
Open access
PDF file
CMConary Meyer
Conary Meyer
YNYusuke Nakamura
Yusuke Nakamura
BRBlake J. Rasor
Blake J. Rasor
AKAshty S. Karim
Ashty S. Karim
MJMichael C. Jewett
Michael C. Jewett
Cheemeng TanCheemeng Tan
Cheemeng Tan
Cell-free synthetic biology is a maturing field that aims to assemble biomolecular reactions outside cells for compelling applications in drug discovery, metabolic engineering, biomanufacturing, diagnostics, and education. Cell-free systems have several key features. They circumvent mechanisms that have evolved to facilitate species survival, bypass limitations on molecular transport across the cell wall, enable high-yielding and rapid synthesis of proteins without creating recombinant cells, and provide high tolerance towards toxic substrates or products. Here, we analyze ~750 published patents and ~2000 peer-reviewed manuscripts in the field of cell-free systems. Three hallmarks emerged. First, we found that both patent filings and manuscript publications per year are significantly increasing (five-fold and 1.5-fold over the last decade, respectively). Second, we observed that the innovation landscape has changed. Patent applications were dominated by Japan in the early 2000s before shifting to China and the USA in recent years. Finally, we discovered an increasing prevalence of biotechnology companies using cell-free systems. Our analysis has broad implications on the future development of cell-free synthetic biology for commercial and industrial applications.

10 May 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
CMConary Meyer
Conary Meyer
AAAlessandra Arizzi
Alessandra Arizzi
THTanner Henson
Tanner Henson
SASharon Aviran
Sharon Aviran
MLMarjorie L. Longo
Marjorie L. Longo
Cheemeng TanCheemeng Tan
Cheemeng Tan
Protein synthesis in natural cells involves intricate interactions between chemical environments, protein-protein interactions, and protein machinery. Replicating such interactions in artificial and cell-free environments can control the precision of protein synthesis, elucidate complex cellular mechanisms, create synthetic cells, and discover new therapeutics. Yet, creating artificial synthesis environments, particularly for membrane proteins, is challenging due to the poorly defined chemical-protein-lipid interactions. Here, we introduce MEMPLEX (Membrane Protein Learning and Expression), which utilizes machine learning and a fluorescent reporter to rapidly design artificial synthesis environments of membrane proteins. MEMPLEX generates over 20,000 different artificial chemical-protein environments spanning 28 membrane proteins. It captures the interdependent impact of lipid types, chemical environments, chaperone proteins, and protein structures on membrane protein synthesis. As a result, MEMPLEX creates new artificial environments that successfully synthesize membrane proteins of broad interest but previously intractable. In addition, we identify a quantitative metric, based on the hydrophobicity of the membrane-contacting amino acids, that predicts membrane protein synthesis in artificial environments. Our work allows others to rapidly study and resolve the “dark” proteome using predictive generation of artificial chemical-protein environments. Furthermore, the results represent a new frontier in artificial intelligence-guided approaches to creating synthetic environments for protein synthesis.

5 January 2022
Verified
Book Chapter
Open access
PDF file
CMConary Meyer
Conary Meyer
CZChuqing Zhou
Chuqing Zhou
ZFZecong Fang
Zecong Fang
MLMarjorie L. Longo
Marjorie L. Longo
Tingrui PanTingrui Pan
Tingrui Pan
Cheemeng TanCheemeng Tan
Cheemeng Tan
Cell-free protein synthesis can enable the combinatorial screening of many different components and concentrations. However, manual pipetting methods are unfit to handle many cell-free reactions. Here, we describe a microfluidic method that can generate hundreds of unique submicroliter scale reactions. The method is coupled with a high yield cell-free system that can be applied for broad protein screening assays. Key words High throughput Cell-free protein synthesis Droplet printing Automation Protein screening Microfluidic adaptive printing Low-volume liquid handling